U.S. flag

An official website of the United States government

NM_006245.4(PPP2R5D):c.592G>A (p.Glu198Lys) AND See cases

Germline classification:
Pathogenic (1 submission)
Last evaluated:
Apr 26, 2021
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV001420208.9

Allele description [Variation Report for NM_006245.4(PPP2R5D):c.592G>A (p.Glu198Lys)]

NM_006245.4(PPP2R5D):c.592G>A (p.Glu198Lys)

Genes:
MEA1:male-enhanced antigen 1 [Gene - OMIM - HGNC]
PPP2R5D:protein phosphatase 2 regulatory subunit B'delta [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
6p21.1
Genomic location:
Preferred name:
NM_006245.4(PPP2R5D):c.592G>A (p.Glu198Lys)
HGVS:
  • NC_000006.12:g.43007265G>A
  • NG_050636.1:g.27767G>A
  • NM_001270476.2:c.139G>A
  • NM_006245.4:c.592G>AMANE SELECT
  • NM_180976.3:c.496G>A
  • NM_180977.3:c.274G>A
  • NP_001257405.1:p.Glu47Lys
  • NP_006236.1:p.Glu198Lys
  • NP_006236.1:p.Glu198Lys
  • NP_851307.1:p.Glu166Lys
  • NP_851308.1:p.Glu92Lys
  • NC_000006.11:g.42975003G>A
  • NM_001270476.2:c.139G>A
  • NM_006245.2:c.592G>A
  • NM_006245.3:c.592G>A
  • Q14738:p.Glu198Lys
  • p.E198K
Protein change:
E166K; GLU198LYS
Links:
UniProtKB: Q14738#VAR_073708; OMIM: 601646.0001
Molecular consequence:
  • NM_001270476.2:c.139G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_006245.4:c.592G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_180976.3:c.496G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_180977.3:c.274G>A - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Name:
See cases [See the Variation display for details]
Identifiers:

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV001622628Genetics Laboratory, UDIAT-Centre Diagnòstic, Hospital Universitari Parc Tauli
criteria provided, single submitter

(Parc Tauli Hospital Assertion Criteria 2021)
Pathogenic
(Apr 26, 2021)
de novoclinical testing

Citation Link

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedde novoyes1not providednot providednot providednot providedclinical testing

Details of each submission

From Genetics Laboratory, UDIAT-Centre Diagnòstic, Hospital Universitari Parc Tauli, SCV001622628.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not provided1not providednot providedclinical testingnot provided

Description

PP5_very strong;PM1_moderate;PM2_supporting;PM6_moderate;PP2_supporting;PP3_supporting

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1de novoyesnot providednot providednot provided1not providednot providednot provided

Last Updated: May 12, 2024